Cellectar Biosciences, Inc. · FWB:NV40

Cellectar Biosciences, Inc. shareholders

As of Sep 30, 2026, 27 institutions reported holding Cellectar Biosciences, Inc., 46.3% of its shares. Largest: Empery Asset Management, LP, Stonepine Capital Management, LLC and Caligan Partners LP. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Cellectar Biosciences, Inc.ChangeFiled
Empery Asset Management, LP955K9.5%+766KNov 16, 2026
Stonepine Capital Management, LLC749K7.5%+644KNov 13, 2026
Caligan Partners LP470K4.7%no changeNov 16, 2026
Janus Henderson466K4.6%first reportNov 16, 2026
Stempoint Capital LP447K4.5%+92,422Nov 16, 2026
Vanguard357K3.6%−16,469Nov 13, 2026
Bleichroeder LP289K2.9%no changeNov 13, 2026
Balyasny Asset Management L.P.220K2.2%no changeNov 16, 2026
Nantahala Capital Management, LLC220K2.2%−220KNov 13, 2026
Silverarc Capital Management, LLC151K1.5%−171KNov 12, 2026

Cellectar Biosciences, Inc. insider trades